Bath & Body Works Balance Sheet Health
Financial Health criteria checks 2/6
Bath & Body Works has a total shareholder equity of $-1.1B and total debt of $3.6B, which brings its debt-to-equity ratio to -319.5%. Its total assets and total liabilities are $5.0B and $6.1B respectively. Bath & Body Works's EBIT is $1.1B making its interest coverage ratio 4.4. It has cash and short-term investments of $820.0M.
Key information
-319.45%
Debt to equity ratio
US$3.61b
Debt
| Interest coverage ratio | 4.4x |
| Cash | US$820.00m |
| Equity | -US$1.13b |
| Total liabilities | US$6.09b |
| Total assets | US$4.96b |
Recent financial health updates
No updates
Recent updates
Analysis Article • 8h
We Think You Can Look Beyond Bath & Body Works' (NYSE:BBWI) Lackluster Earnings
The market was pleased with the recent earnings report from Bath & Body Works, Inc. ( NYSE:BBWI ), despite the profit...
Narrative Update • Jun 02
BBWI: Turnaround Efforts And Cost Controls Will Likely Offset Macro Pressures
Analysts have trimmed the Bath & Body Works fair value estimate from $22.00 to $19.00. This reflects a series of lower Street price targets around $19 to $23, as they balance concerns about ongoing category pressure, macro and inflation headwinds, and execution risk against early signs of cost control and the company's longer term turnaround efforts.Analysis Article • May 29
Bath & Body Works, Inc. Just Beat EPS By 215%: Here's What Analysts Think Will Happen Next
Shareholders of Bath & Body Works, Inc. ( NYSE:BBWI ) will be pleased this week, given that the stock price is up 18...Seeking Alpha • May 27
Bath & Body Works Q1 Recap: Clean Quarter, Shares Fairly Valued
Summary Bath & Body Works, Inc. just reported its Q1, and the results came in ahead of expectations. The struggling personal-care retailer is in the midst of an operational turnaround in an effort to return the business to growth. Today’s BBWI results show progress, though there is clearly still a journey ahead. While BBWI shares appear to be a value at around 7x forward earnings, I see the stock as appropriately priced at current levels. Read the full article on Seeking AlphaNarrative Update • May 11
BBWI: Amazon Storefront And Turnaround Plan Will Likely Drive Future Upside
Analysts have nudged their average price targets for Bath & Body Works higher into the low to mid $20s, citing Q4 results that were better than expected for several firms, updated models, and management's refreshed business strategy, while still highlighting ongoing pressure on sales trends and margins into 2026. Analyst Commentary Across recent research, most firms adjusted their models for Bath & Body Works following Q4 results and the updated business strategy.
Narrative Update • Apr 27
BBWI: Amazon Launch And Turnaround Plan Will Support Post 2026 Margin Recovery
Narrative Update: Bath & Body Works Analysts have modestly lifted the average price target for Bath & Body Works to about $25 to $26. This reflects Q4 results that were better than expected, alongside mixed views on ongoing margin pressure, turnaround efforts, and the updated long term growth strategy.Narrative Update • Apr 13
BBWI: Core Product Reset And Amazon Launch Will Support Post 2026 Margin Recovery
Narrative Update The updated analyst framework lifts the illustrative price target for Bath & Body Works by about $3 per share to roughly $28. Analysts cite better than expected Q4 performance, refreshed long term business plans, model updates following recent results, and an expectation for some P/E multiple expansion, even as they highlight ongoing topline and margin pressures and mixed views on the core business.
Narrative Update • Mar 31
BBWI VALUATION
julio has decreased revenue growth from 5.7% to 3.2% and decreased future PE multiple from 12.0x to 8.0x.Narrative Update • Mar 30
BBWI: Amazon Launch And Turnaround Execution Will Likely Drive Future Upside
Bath & Body Works' analyst fair value estimate has increased from $17.00 to $22.00 following better than expected Q4 results, updated models, and a shift in business strategy that supports higher future P/E assumptions, despite ongoing pressure on margins and topline expectations. Analyst Commentary Recent research on Bath & Body Works points to a more nuanced setup, with several firms lifting price targets after Q4 yet keeping a relatively restrained stance on ratings and longer term growth expectations.
New Narrative • Mar 16
Bath & Body Works is a dominant, high-quality consumer brand with near-perfect business economics, temporarily depressed by a demand trough
Most investors look at BBWI and see a mall candle retailer. That framing undersells it significantly.
Narrative Update • Mar 16
BBWI: Turnaround Execution And Amazon Rollout Will Drive Future Upside
Analysts have trimmed the Bath & Body Works fair value estimate to about $44.60, even as several Street price targets now cluster in the low to high $20s. This reflects updated views on slower revenue growth, slightly softer margins, a higher discount rate, and a lower assumed future P/E multiple.Narrative Update • Mar 02
BBWI: Weak Core And Amazon Expansion Will Likely Restrain Future Upside
Narrative Update: Bath & Body Works Analysts have inched their average price target for Bath & Body Works higher by $1 to $22. This reflects a view that recent target increases, balanced upside and downside into Q4 earnings, and ongoing concerns about a weaker core business and the need for more investment leave the risk and reward relatively even at current levels.Narrative Update • Feb 16
BBWI: Earnings Reset And Legal Headwinds Will Likely Cap Near Term Upside
Narrative Update The updated analyst price target for Bath & Body Works shifts toward the mid to high teens, around $17 to $21. Analysts generally point to mixed recent earnings, reset expectations for sales and margins into 2026, and a more cautious stance on revenue trends and valuation multiples.Narrative Update • Feb 02
BBWI: Core Product Refocus And Digital Reset Will Support Post 2026 Margin Recovery
Analysts have inched up their Bath & Body Works fair value estimate to about $24.62 per share, reflecting slightly higher assumed revenue growth and P/E multiples, partly tempered by softer margin expectations and a series of cautious Hold and Neutral ratings following recent earnings and guidance resets. Analyst Commentary Recent Street research on Bath & Body Works has clustered around Hold, Neutral, Equal Weight, and Market Perform ratings, with several firms cutting price targets following the latest Q3 miss and Q4 guidance reset.Narrative Update • Jan 19
BBWI: Earnings Reset And Margin Pressure Will Likely Cap Near Term Upside
Analysts have cut their fair value estimate for Bath & Body Works from US$32 to US$17, reflecting softer revenue and margin expectations, a higher discount rate, and a reset in forward P/E assumptions following Q3 earnings misses, cautious Q4 guidance, and a series of price target reductions and downgrades across the Street. Analyst Commentary Recent Street research on Bath & Body Works has shifted toward a more cautious stance, with several firms resetting ratings and price targets following the Q3 earnings miss and weaker Q4 outlook.Narrative Update • Jan 05
BBWI: Digital And Distribution Improvements Will Support Post 2026 Margin Recovery
Bath & Body Works' analyst price targets have moved sharply lower into a roughly mid to high teens US$ range, as analysts respond to Q3 earnings misses, reduced Q4 guidance, softer sales trends and weaker margins that have led to a series of downgrades and concerns about near term revenue and margin visibility. Analyst Commentary Recent research updates show a clear reset in expectations for Bath & Body Works, with price targets clustered in the mid to high teens and ratings generally moved to Neutral or equivalent.Analysis Article • Dec 21
Bath & Body Works, Inc. (NYSE:BBWI) Stock Catapults 33% Though Its Price And Business Still Lag The Market
Bath & Body Works, Inc. ( NYSE:BBWI ) shareholders are no doubt pleased to see that the share price has bounced 33% in...Narrative Update • Dec 18
BBWI: Digital And Distribution Improvements Will Support Margin Recovery After 2026 Reset
Analysts have modestly reduced our Bath & Body Works fair value estimate, despite a small uptick in modeled revenue growth and profit margin and a slightly higher future P E multiple. This reflects a broad reset in Street price targets to the mid to high teens after disappointing Q3 results, weaker guidance, and expectations that meaningful topline and margin recovery will not materialize until 2026.Narrative Update • Dec 04
BBWI: Digital And Distribution Improvements Will Drive Stronger Margins After 2026 Reset
Analysts have sharply reduced their price target on Bath & Body Works, cutting fair value from approximately $37 to about $24 as they factor in weaker near term revenue growth, modest margin pressure, and lower future earnings multiples amid broad downgrades and reset expectations through 2026. Analyst Commentary Recent Street research reflects a sharp turn in sentiment on Bath & Body Works, with multiple firms cutting ratings and price targets following a disappointing Q3 print and weaker Q4 outlook.Analysis Article • Nov 23
Earnings Miss: Bath & Body Works, Inc. Missed EPS By 5.1% And Analysts Are Revising Their Forecasts
As you might know, Bath & Body Works, Inc. ( NYSE:BBWI ) last week released its latest quarterly, and things did not...Analysis Article • Nov 20
Bath & Body Works' (NYSE:BBWI) Dividend Will Be $0.20
Bath & Body Works, Inc.'s ( NYSE:BBWI ) investors are due to receive a payment of $0.20 per share on 5th of December...Narrative Update • Nov 20
BBWI: Margins Will Strengthen As Digital And Distribution Efforts Gain Traction
Analysts have lowered their average price target for Bath & Body Works by nearly $1 to approximately $37. They cite recent challenges with digital improvements, increased discounting, and limited progress in reducing promotions as key factors influencing their outlook.Narrative Update • Nov 05
BBWI: Sales Will Face Margin Pressure Amid Heavy Promotions
Analysts have modestly reduced their price targets for Bath & Body Works, with updated estimates reflecting a decrease of approximately $1. They now cite ongoing promotional activity and macroeconomic uncertainty as factors limiting near-term upside.Narrative Update • Oct 22
Analysts Cite Mixed Outlook for Bath & Body Works as Price Target Edges Lower
The analyst price target for Bath & Body Works was revised slightly downward from $39.33 to $38.83. Analysts cited continued heavy promotions, mixed results from product launches, and ongoing macroeconomic challenges that are limiting near-term sales and margin improvements.Narrative Update • Oct 08
Digital Transformation And Global Expansion Will Build A Robust Future
Analysts have slightly lowered their price target for Bath & Body Works, trimming the estimate from $41 to $40. Updated forecasts suggest softer revenue growth and profit margin ahead following the latest quarterly results.Narrative Update • Sep 04
Digital Transformation And Global Expansion Will Build A Robust Future
With consensus revenue growth and discount rate forecasts for Bath & Body Works both remaining stable, the analyst fair value target also stayed unchanged at $40.73. What's in the News Bath & Body Works revised its full-year 2025 sales growth guidance to 1.5%-2.7% (from 1%-3%) and lowered EPS expectations to $3.28–$3.53, below fiscal 2024’s $3.61.Analysis Article • Aug 31
Bath & Body Works, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Last week, you might have seen that Bath & Body Works, Inc. ( NYSE:BBWI ) released its second-quarter result to the...Analysis Article • Aug 20
Bath & Body Works (NYSE:BBWI) Has Announced A Dividend Of $0.20
Bath & Body Works, Inc.'s ( NYSE:BBWI ) investors are due to receive a payment of $0.20 per share on 5th of September...Analysis Article • Aug 06
Bath & Body Works, Inc.'s (NYSE:BBWI) Intrinsic Value Is Potentially 53% Above Its Share Price
NYSE:BBWI 1 Year Share Price vs Fair Value Explore Bath & Body Works's Fair Values from the Community and select yours...Analysis Article • Jul 16
Weekly Picks: 📈 MSTR's Leveraged Bitcoin Exposure, QS' Breakthrough Battery Tech, and BBWI's Turnaround Potential
📈 Why Strategy is a compelling vehicle to gain leveraged Bitcoin exposure. 💰 How debt reduction is a key driver to Bath & Body Works' success. 🔋 Why QuantumScape’s technology could solve all current EV problems.New Narrative • Jul 15
Emerging Markets and Debt Reduction Will Propel Bath & Body Works Forward
Bath and Body Works is an interesting company to try and project for since it has so many irregular attributes that make it trickier to predict future growth because of. The biggest reason it becomesAnalysis Article • Jul 09
Bath & Body Works, Inc. (NYSE:BBWI) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Bath & Body Works, Inc. ( NYSE:BBWI ) shares have had a really impressive month, gaining 26% after a shaky period...Analysis Article • May 19
Bath & Body Works' (NYSE:BBWI) Dividend Will Be $0.20
The board of Bath & Body Works, Inc. ( NYSE:BBWI ) has announced that it will pay a dividend on the 20th of June, with...Analysis Article • May 09
Earnings Working Against Bath & Body Works, Inc.'s (NYSE:BBWI) Share Price
Bath & Body Works, Inc.'s ( NYSE:BBWI ) price-to-earnings (or "P/E") ratio of 8.5x might make it look like a strong buy...Seeking Alpha • Apr 14
Bath & Body Works: Debt Is One Of Two Good Income Options
Summary Bath & Body Works faces industry challenges and trade war impacts but offers attractive income options through its long-term debt and put options. Despite sales declines, the company maintains a healthy gross profit margin and has improved its equity position by reducing long-term debt. Operating cash flow remains strong, supporting dividends, debt repayment, and stock repurchases, with stable free cash flow since the pandemic. Conservative investors can benefit from the company's 7.4% yielding bonds, while higher risk-tolerant investors might consider short-term put options for income. Read the full article on Seeking AlphaSeeking Alpha • Apr 09
Bath & Body Works: Rating Downgrade On Macro Turmoil And Potential EPS Miss
Summary I downgraded Bath & Body Works Inc. from hold to sell, due to macroeconomic turmoil and potential EPS guidance misses. Recent tariffs and macro developments threaten BBWI's turnaround, impacting consumer spending and increasing reliance on promotions, which could hurt margins. Inventory levels are rising, suggesting the potential for aggressive discounting, further pressuring earnings and merchandise margins. Valuation concerns arise as consensus estimates haven't priced in new tariffs, risking BBWI missing estimates and leading to further stock de-rating. Read the full article on Seeking AlphaSeeking Alpha • Mar 04
Bath & Body Works: Undervalued Despite Materializing Tariff Headwind
Summary Bath & Body Works, Inc. ended FY2024 on a strong note as earnings performed stably comparably. The FY2025 outlook stands worse than expected. Further, Trump's 25% tariffs on Canada & Mexico, and an additional 10% tariff on China could have a negative impact on earnings. Supply chain management could mitigate some of the negative impacts, and Bath & Body Works' high margins should still enable quite stable earnings despite the headwind. I still estimate BBWI stock to be undervalued with a 43% upside to a fair value of $47.6. Read the full article on Seeking AlphaAnalysis Article • Feb 10
Bath & Body Works (NYSE:BBWI) Is Paying Out A Dividend Of $0.20
The board of Bath & Body Works, Inc. ( NYSE:BBWI ) has announced that it will pay a dividend on the 7th of March, with...Financial Position Analysis
Short Term Liabilities: BBWI has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: BBWI has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: BBWI has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: BBWI's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: BBWI's debt is well covered by operating cash flow (32.1%).
Interest Coverage: BBWI's interest payments on its debt are well covered by EBIT (4.4x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/08 16:52 |
| End of Day Share Price | 2026/06/08 00:00 |
| Earnings | 2026/05/02 |
| Annual Earnings | 2026/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bath & Body Works, Inc. is covered by 40 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Mark Altschwager | Baird |
| Matthew McClintock | Barclays |